Phreesia, Inc. (NYSE:PHR) Given Consensus Rating of “Buy” by Brokerages

Phreesia, Inc. (NYSE:PHR) has earned a consensus rating of “Buy” from the twelve brokerages that are covering the company, MarketBeat.com reports. Twelve analysts have rated the stock with a buy recommendation. The average 12-month price objective among brokers that have covered the stock in the last year is $31.00.

A number of analysts recently issued reports on the company. JMP Securities restated a “market outperform” rating and issued a $30.00 price target on shares of Phreesia in a research report on Tuesday, December 10th. Truist Financial lifted their price target on shares of Phreesia from $31.00 to $34.00 and gave the stock a “buy” rating in a research note on Wednesday, December 11th. Royal Bank of Canada raised shares of Phreesia from a “sector perform” rating to an “outperform” rating and raised their price objective for the stock from $24.00 to $32.00 in a research note on Wednesday, January 8th. Citigroup boosted their price objective on Phreesia from $31.00 to $35.00 and gave the company a “buy” rating in a report on Friday, January 10th. Finally, Needham & Company LLC restated a “buy” rating and issued a $29.00 target price on shares of Phreesia in a research note on Friday, January 10th.

Phreesia Stock Performance

Phreesia stock opened at $27.12 on Thursday. The company’s 50-day moving average price is $23.18 and its 200-day moving average price is $22.71. The company has a quick ratio of 1.77, a current ratio of 1.74 and a debt-to-equity ratio of 0.04. The company has a market cap of $1.58 billion, a PE ratio of -18.45 and a beta of 0.94. Phreesia has a twelve month low of $17.07 and a twelve month high of $29.16.

Phreesia (NYSE:PHR) last issued its quarterly earnings data on Monday, December 9th. The company reported ($0.25) earnings per share for the quarter, topping the consensus estimate of ($0.29) by $0.04. The company had revenue of $106.80 million for the quarter, compared to analysts’ expectations of $106.33 million. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The firm’s revenue for the quarter was up 16.6% on a year-over-year basis. During the same period in the previous year, the firm posted ($0.58) earnings per share. On average, equities research analysts forecast that Phreesia will post -1.16 EPS for the current fiscal year.

Insider Activity at Phreesia

In other Phreesia news, SVP David Linetsky sold 11,853 shares of the firm’s stock in a transaction that occurred on Wednesday, December 11th. The shares were sold at an average price of $24.85, for a total value of $294,547.05. Following the completion of the sale, the senior vice president now directly owns 188,354 shares in the company, valued at $4,680,596.90. This trade represents a 5.92 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Amy Beth Vanduyn sold 1,311 shares of the company’s stock in a transaction on Monday, January 6th. The stock was sold at an average price of $26.61, for a total value of $34,885.71. Following the transaction, the senior vice president now directly owns 115,633 shares in the company, valued at approximately $3,076,994.13. The trade was a 1.12 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 92,962 shares of company stock valued at $2,181,223 over the last quarter. 5.80% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. Versor Investments LP acquired a new stake in Phreesia in the third quarter worth about $694,000. Zacks Investment Management acquired a new stake in Phreesia in the 3rd quarter worth approximately $631,000. Sei Investments Co. boosted its stake in Phreesia by 135.3% in the 2nd quarter. Sei Investments Co. now owns 165,327 shares of the company’s stock worth $3,505,000 after purchasing an additional 95,058 shares in the last quarter. State Street Corp grew its position in Phreesia by 7.1% during the 3rd quarter. State Street Corp now owns 1,327,586 shares of the company’s stock worth $30,256,000 after purchasing an additional 88,517 shares during the last quarter. Finally, Franklin Resources Inc. raised its holdings in shares of Phreesia by 3.0% in the third quarter. Franklin Resources Inc. now owns 1,497,631 shares of the company’s stock worth $31,495,000 after buying an additional 42,973 shares during the last quarter. 92.10% of the stock is currently owned by hedge funds and other institutional investors.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.